Taneli Jouhikainen

2017

In 2017, Taneli Jouhikainen earned a total compensation of $600.2K as Chief Operating Officer & President at Mast Therapeutics.

Compensation breakdown

Bonus$276,750
Non-Equity Incentive Plan$90,750
Salary$210,938
Other$21,750
Total$600,188

Jouhikainen received $276.8K in bonus, accounting for 46% of the total pay in 2017.

Jouhikainen also received $90.8K in non-equity incentive plan, $210.9K in salary and $21.8K in other compensation.

Rankings

In 2017, Taneli Jouhikainen's compensation ranked 11,197th out of 14,666 executives tracked by ExecPay. In other words, Jouhikainen earned more than 23.7% of executives.

ClassificationRankingPercentile
All
11,197
out of 14,666
24th
Division
Manufacturing
4,387
out of 5,772
24th
Major group
Chemicals And Allied Products
1,592
out of 2,075
23rd
Industry group
Drugs
1,311
out of 1,731
24th
Industry
Pharmaceutical Preparations
1,025
out of 1,333
23rd
Source: SEC filing on April 23, 2018.

Jouhikainen's colleagues

We found six more compensation records of executives who worked with Taneli Jouhikainen at Mast Therapeutics in 2017.

2017

Brian Culley

Mast Therapeutics

Chief Executive Officer

2017

Edwin Parsley

Mast Therapeutics

Former Chief Medical Office & Senior Vice President

2017

Brandi Roberts

Mast Therapeutics

Chief Financial Officer

2017

Robert Neville

Mast Therapeutics

Chief Executive Officer

2017

Shana Hood

Mast Therapeutics

General Counsel

2017

Dave Lowrance

Mast Therapeutics

Chief Financial Officer

News

You may also like